Neuro, Cognitive & Sleep Research blend
IllumiNeuro-60 IN60
Neuro blend
Four-component research blend of N-acetyl Semax, N-acetyl Selank, Pinealon and PE 22-28, each studied separately in neuropeptide research.
Evidence level. Evidence comes mainly from animal or other preclinical models. For a blend, the rating covers the combination itself; each component has its own profile. About the badges
- Class
- Neuro blend
- Category
- Neuro, Cognitive & Sleep
- Type
- Research blend
- Abbreviation
- IN60
- Development and regulatory status
- Research blend; components not approved drugs; blend itself unstudied
Blend composition
What researchers study
Four-component research blend: N-acetylated forms of Semax and Selank, the short peptide Pinealon, and PE 22-28, a spadin-derived TREK-1 channel inhibitor. Components are studied separately; no blend-level studies were located.
Research areas
- Combined cognitive, mood and neuroprotection studies
- TREK-1 channel and mood-pathway models
- Neurotrophin-expression studies in rodents
- Comparative short-peptide cell-culture studies
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- cell culture
PE 22-28 inhibited human TREK-1 in HEK cells with an IC50 of 0.12 nM versus 40-60 nM for spadin
- rodent
Semax raised hippocampal BDNF protein 1.4-fold after a single application in rats
Studied alongside
Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.
